col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Elsevier: Vaccine
  original article Date Title Authors   All Authors
1 [GO] 2021―Jul―24 COVID-19 vaccination for cancer patients: evidence, priority, and practice Shiv Rajan, Naseem Akhtar, Sonali Sharma, Deep Chakrabarti, Vijay Kumar
2 [GO] 2021―Jul―24 Association of total and neutralizing SARS-CoV-2 spike -Receptor Binding Domain antibodies with epidemiological and clinical characteristics after immunization with the 1st and 2nd doses of the BNT162b2 vaccine Athanasios Michos, Elizabeth-Barbara Tatsi, Fillipos Filippatos, Charilaos Dellis, Dimitra Koukou, Vasiliki Efthymiou, et al. (+3)
3 [GO] 2021―Jul―24 Quantification of SARS-CoV-2 spike and nucleocapsid proteins using isotope dilution tandem mass spectrometry Carrie Pierce-Ruiz, Wanda I. Santana, William J. H. Sutton, David A. Fischler, Hans C. Cooper, Lidoshka R. Marc, et al. (+2)
4 [GO] 2021―Jul―23 Parental plans to vaccinate children for COVID-19 in New York City Chloe A. Teasdale, Luisa N. Borrell, Yanhan Shen, Spencer Kimball, Michael L. Rinke, Sasha A. Fleary, Denis Nash
5 [GO] 2021―Jul―23 Background rates of all-cause mortality, hospitalizations, and emergency department visits among nursing home residents in Ontario, Canada to inform COVID-19 vaccine safety assessments Maria Sundaram, Sharifa Nasreen, Andrew Calzavara, Siyi He, Hannah Chung, Susan E. Bronskill, et al. (+6)
6 [GO] 2021―Jul―23 Enablers and barriers to COVID-19 vaccine uptake: an international study of perceptions and intentions Paul F. Burke, Daniel Masters, Graham Massey
7 [GO] 2021―Jul―22 Patients with history of covid-19 had more side effects after the first dose of covid-19 vaccine Noémie Tissot, Anne-Sophie Brunel, Fabienne Bozon, Béatrice Rosolen, Catherine Chirouze, Kevin Bouiller
8 [GO] 2021―Jul―22 Will COVID-19 vaccine equity be possible in India? Kanagavalli Mathivathanan
9 [GO] 2021―Jul―20 Playing vaccine roulette: Why the current strategy of staking everything on Covid-19 vaccines is a high-stakes wager Elisabeth Paul, Garrett W. Brown, Andreas Kalk, Valéry Ridde
10 [GO] 2021―Jul―16 An enveloped virus-like particle vaccine expressing a stabilized prefusion form of the SARS-CoV-2 spike protein elicits highly potent immunity Anne-Catherine Fluckiger, Barthelemy Ontsouka, Jasminka Bozic, Abebaw Diress, Tanvir Ahmed, Tamara Berthoud, et al. (+7)
11 [GO] 2021―Jul―16 Vitamin D supplementation: an alternative to enhance the effectiveness of vaccines against SARS-CoV-2? Felipe Inserra, Carlos Tajer, Laura Antonietti, Javier Mariani, León Ferder, Walter Manucha
12 [GO] 2021―Jul―13 Marketing the COVID-19 vaccine and the implications for public health Emmanuel Mogaji
13 [GO] 2021―Jul―13 COVID-19 Vaccine Capacity: Challenges and Mitigation - The DCVMN perspective Benoit Hayman, Rajinder Suri, Sai D. Prasad
14 [GO] 2021―Jul―13 The Novel Platform of mRNA COVID-19 Vaccines and Myocarditis: Clues into the Potential Underlying Mechanism George Lazaros, Allan L. Klein, Sophia Hatziantoniou, Costas Tsioufis, Athanasios Tsakris, Cleo Anastassopoulou
15 [GO] 2021―Jul―10 Thrombosis with Thrombocytopenia Syndrome (TTS) following AstraZeneca ChAdOx1 nCoV-19 (AZD1222) COVID-19 vaccination - a risk-benefit analysis for people <60 years in Australia Chandini Raina MacIntyre, Benjamin Veness, David Berger, Nada Hamad, Noor Bari
16 [GO] 2021―Jul―07 Initial impact of SARS-Cov-2 vaccination on healthcare workers in Italy- Update on the 28th of March 2021 Alberto Mateo-Urdiales, Martina Del Manso, Xanthi Andrianou, Matteo Spuri, Fortunato D'Ancona, Antonietta Filia, et al. (+7)
17 [GO] 2021―Jun―30 Henoch-Schönlein Purpura Presenting Post COVID-19 Vaccination Adam M. Hines, Neal Murphy, Christine Mullin, Julia Barillas, Jacqueline C. Barrientos
18 [GO] 2021―Jun―29 Cost of vaccine delivery strategies in low- and middle-income countries during the COVID-19 pandemic Christina Banks, Allison Portnoy, Flavia Moi, Laura Boonstoppel, Logan Brenzel, Stephen C. Resch
19 [GO] 2021―Jun―29 COVID-19 vaccine roll-out in middle-income countries: lessons learned from the Jordan experience Ala'a Al-Shaikh, Nazeema Muthu, Chinara Aidyralieva, Maria Cristina Profili, Saverio Bellizzi
20 [GO] 2021―Jun―26 Significance of SARS-CoV-2 Specific Antibody Testing during COVID-19 Vaccine Allocation Akane B. Fujimoto, Inci Yildirim, Pinar Keskinocak
21 [GO] 2021―Jun―26 Laser-facilitated epicutaneous immunization of mice with SARS-CoV-2 spike protein induces antibodies inhibiting spike/ACE2 binding Sandra Scheiblhofer, Stephan Drothler, Werner Braun, Reinhard Braun, Maximilian Boesch, Richard Weiss
22 [GO] 2021―Jun―25 Specialist confirmed allergic reactions to COVID-19 mRNA vaccines at a mass vaccination site Ian A Myles, Joshua S Vinciguerra, Robert T Premus
23 [GO] 2021―Jun―23 Tolerance of BNT162b2 mRNA COVI-19 vaccine in patients with a medical history of COVID-19 disease : a case control study Aurelie Baldolli, Jocelyn Michon, Fanny Appia, Caroline Galimard, Renaud Verdon, Jean Jacques Parienti
24 [GO] 2021―Jun―23 Relationship between pre-existing allergies and anaphylactic reactions post mRNA COVID-19 vaccine administration Aditya P. Desai, Aryan P. Desai, Gregory J. Loomis
25 [GO] 2021―Jun―23 Trust in government, intention to vaccinate and COVID-19 vaccine hesitancy: a comparative survey of five large cities in the United States, United Kingdom, and Australia Mallory Trent, Holly Seale, Abrar Ahmad Chughtai, Daniel Salmon, C. Raina MacIntyre
26 [GO] 2021―Jun―23 One or two dose regimen of the SARS-CoV-2 synthetic DNA vaccine INO-4800 protects against respiratory tract disease burden in nonhuman primate challenge model Karen E. Gooch, Trevor R.F. Smith, Francisco J. Salguero, Susan A. Fotheringham, Robert J. Watson, Mike J. Dennis, et al. (+19)
27 [GO] 2021―Jun―22 Adapting the Motors of Influenza Vaccination Acceptance Scale into the Motors of COVID-19 Vaccination Acceptance Scale: Psychometric evaluation among mainland Chinese university students I-Hua Chen, Daniel Kwasi Ahorsu, Nai-Ying Ko, Cheng-Fang Yen, Chung-Ying Lin, Mark D. Griffiths, Amir H. Pakpour
28 [GO] 2021―Jun―22 Recent MMR vaccination in Health Care Workers and Covid-19: a test negative case-control study Lisa Lundberg, Maria Bygdell, Gustaf Stukat von Feilitzen, Susanne Woxenius, Claes Ohlsson, Jenny M Kindblom, Susannah Leach
29 [GO] 2021―Jun―21 Should older adult pneumococcal vaccination recommendations change due to decreased vaccination in children during the pandemic? A cost-effectiveness analysis Kenneth J. Smith, Angela R. Wateska, Mary Patricia Nowalk, Chyongchiou J. Lin, Lee H. Harrison, William Schaffner, Richard K. Zimmerman
30 [GO] 2021―Jun―17 Early influenza vaccination rates in children during the COVID-19 pandemic Benjamin Fogel, Eric W. Schaefer, Steven D. Hicks
31 [GO] 2021―Jun―17 COVID-19 Vaccination Rates Vary By Community Vulnerability: A County-level Analysis Clare C. Brown, Sean G. Young, George C. Pro
32 [GO] 2021―Jun―15 Title: Helping patients with ethical concerns about COVID-19 vaccines in light of fetal cell lines used in some COVID-19 vaccines Richard K Zimmerman
33 [GO] 2021―Jun―14 The Need for Broadly Protective COVID-19 Vaccines: Beyond S-Only Approaches Gregory A. Poland, Inna G. Ovsyannikova, Richard B. Kennedy
34 [GO] 2021―Jun―12 COVID-19 RELATED IMMUNIZATION DISRUPTIONS IN RAJASTHAN, INDIA: A RETROSPECTIVE OBSERVATIONAL STUDY Radhika Jain, Ambika Chopra, Camille Falézan, Mustufa Patel, Pascaline Dupas
35 [GO] 2021―Jun―12 Long-term antibody persistence and exceptional vaccination response on previously SARS-CoV-2 infected subjects Davide Ferrari, Chiara Di Resta, Rossella Tomaiuolo, Eleonora Sabetta, Marina Pontillo, Andrea Motta, Massimo Locatelli
36 [GO] 2021―Jun―10 Estimating the number of averted illnesses and deaths as a result of vaccination against an influenza pandemic in nine low- and middle-income countries Chelsea S. Lutz, Matthew Biggerstaff, Melissa A. Rolfes, Kathryn E. Lafond, Eduardo Azziz-Baumgartner, Rachael M. Porter, et al. (+2)
37 [GO] 2021―Jun―09 Twitter discourse reveals geographical and temporal variation in concerns about COVID-19 Vaccines in the United States Sharath Chandra Guntuku, Alison M. Buttenheim, Garrick Sherman, Raina M. Merchant
38 [GO] 2021―Jun―08 A new group at increased risk of a SARS-CoV-2 infection emerges: The recently vaccinated Sebastian Hoehl, Sandra Ciesek, Jürgen Graf, Sabine Wicker
39 [GO] 2021―Jun―07 Knowledge and attitude of Kenyan healthcare workers towards pandemic influenza disease and vaccination: 9 years after the last influenza pandemic Fred Andayi, Gideon O. Emukule, Eric Osoro, Linus K. Ndegwa, Fredrick Otiato, Peter Muturi, et al. (+7)
40 [GO] 2021―Jun―05 One size does not fit all: Lessons from Israel's Covid-19 vaccination drive and hesitancy Aviad Raz, Yael Keshet, Ariela Popper-Giveon, Maha Sabbah Karkabi
41 [GO] 2021―Jun―04 Public trust on regulatory decisions: the European Medicines Agency and the AstraZeneca COVID-19 vaccine label Rafael Dal-Ré, Odile Launay
42 [GO] 2021―Jun―01 Impact of the COVID-19 pandemic on the provision of routine childhood immunizations in Ontario, Canada Pierre-Philippe Piché-Renaud, Catherine Ji, Daniel S. Farrar, Jeremy N. Friedman, Michelle Science, Ian Kitai, et al. (+3)
43 [GO] 2021―Jun―01 Evaluation of post-introduction COVID-19 Vaccine Effectiveness: Summary of interim guidance of the World Health Organization Minal K. Patel, Isabel Bergeri, Joseph S. Bresee, Benjamin J. Cowling, Natasha S. Crowcroft, Kamal Fahmy, et al. (+21)
44 [GO] 2021―Jun―01 Immunogenic Potential of DNA Vaccine candidate, ZyCoV-D against SARS-CoV-2 in Animal Models Ayan Dey, T.M. Chozhavel Rajanathan, Harish Chandra, Hari P.R. Pericherla, Sanjeev Kumar, Huzaifa S. Choonia, et al. (+14)
45 [GO] 2021―May―30 The missing season: The impacts of the COVID-19 pandemic on influenza Casey M. Zipfel, Vittoria Colizza, Shweta Bansal
46 [GO] 2021―May―28 Myocarditis following COVID-19 mRNA vaccination Saif Abu Mouch, Ariel Roguin, Elias Hellou, Amorina Ishai, Uri Shoshan, Lamis Mahamid, et al. (+4)
47 [GO] 2021―May―28 Adverse Events Following mRNA SARS-CoV-2 Vaccination among U.S. Nursing Home Residents Barbara H. Bardenheier, Stefan Gravenstein, Carolyn Blackman, Roee Gutman, Indra Neil Sarkar, Richard A. Feifer, et al. (+4)
48 [GO] 2021―May―27 COVID-19 vaccine hesitancy: lessons from Israel David Gurwitz
49 [GO] 2021―May―26 Willingness to get vaccinated against Covid-19 and attitudes towards vaccination in general Roselinde Kessels, Jeroen Luyten, Sandy Tubeuf
50 [GO] 2021―May―24 A breath of humanity in the era of Covid-19 vaccine Philippe Vanhems
51 [GO] 2021―May―24 Evidence for antibody as a protective correlate for COVID-19 vaccines Kristen A. Earle, Donna M. Ambrosino, Andrew Fiore-Gartland, David Goldblatt, Peter B. Gilbert, George R. Siber, et al. (+2)
52 [GO] 2021―May―21 Changes in Childhood Vaccination During the Coronavirus Disease 2019 Pandemic in Japan Yuta Aizawa, Tomohiro Katsuta, Hiroshi Sakiyama, Keiko Tanaka-Taya, Hiroyuki Moriuchi, Akihiko Saitoh
53 [GO] 2021―May―21 Lessons from the 1656 Neapolitan Plague:Something to Learn for the Current Coronavirus Pandemic? Maurizio Bifulco, Simona Pisanti, Idamaria Fusco
54 [GO] 2021―May―19 The first Chinese national standards for SARS-CoV-2 neutralizing antibody Lidong Guan, Yuanling Yu, Xiaohong Wu, Jianhui Nie, Jun Zhang, Zejun Wang, et al. (+10)
55 [GO] 2021―May―18 An mRNA-based vaccine candidate against SARS-CoV-2 elicits stable immuno-response with single dose Kakon Nag, Juwel Chandra Baray, Maksudur Rahman Khan, Asif Mahmud, Jikrul Islam, Sanat Myti, et al. (+20)
56 [GO] 2021―May―18 Prevalence and determinants of SARS-CoV-2 vaccine hesitancy in Hong Kong: a population-based survey Tzu Tsun LUK, Shengzhi ZHAO, Yongda WU, Janet Yuen-ha WONG, Man Ping WANG, Tai Hing LAM
57 [GO] 2021―May―14 Operational research for the safe and effective design of COVID-19 mass vaccination centres Richard M. Wood, Ben J. Murch, Simon J. Moss, Joshua M.B. Tyler, Alexander L. Thompson, Christos Vasilakis
58 [GO] 2021―May―14 U.S. Population-Based Background Incidence Rates of Medical Conditions for Use in Safety Assessment of COVID-19 Vaccines Diane Gubernot, Amelia Jazwa, Manette Niu, Jane Baumblatt, Julianne Gee, Pedro Moro, et al. (+12)
59 [GO] 2021―May―12 COVID-19 vaccine hesitancy among persons living in homeless shelters in France C Longchamps, S Ducarroz, L Crouzet, N. Vignier, L. Pourtau, C Allaire, et al. (+3)
60 [GO] 2021―May―12 Older Adolescents and Young Adults Willingness to Receive the COVID-19 Vaccine: Implications for Informing Public Health Strategies Tracie O. Afifi, Samantha Salmon, Tamara Taillieu, Ashley Stewart-Tufescu, Janique Fortier, S. Michelle Driedger
61 [GO] 2021―May―11 Covid-19 vaccine trials: ethnic diversity and immunogenicity Hannah Jethwa, Richard Wong, Sonya Abraham
62 [GO] 2021―May―09 Influenza and pneumococcal vaccinations are not associated to COVID-19 outcomes among patients admitted to a university hospital Roberta Pastorino, Leonardo Villani, Daniele Ignazio La Milia, Roberto Ieraci, Francesco Chini, Enrico Volpe, et al. (+5)
63 [GO] 2021―May―06 Sex differences in the incidence of anaphylaxis to LNP-mRNA COVID-19 vaccines Masaharu Somiya, Sohtaro Mine, Kosuke Yasukawa, Saki Ikeda
64 [GO] 2021―Apr―30 Strengthening and accelerating SARS-CoV-2 vaccine safety surveillance through registered pre-approval rollout after challenge tests Nir Eyal, Tobias Gerhard, Brian L. Strom
65 [GO] 2021―Apr―30 Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS) Kerry J. Welsh, Jane Baumblatt, Wambui Chege, Ravi Goud, Narayan Nair
66 [GO] 2021―Apr―27 Missed childhood immunizations during the COVID-19 pandemic in Brazil: analyses of routine statistics and of a national household survey Mariangela F Silveira, Cristian T Tonial, Ana Goretti K Maranhão, Antonia MS Teixeira, Pedro C Hallal, Ana Maria B Menezes, et al. (+4)
67 [GO] 2021―Apr―27 Childhood immunization during the COVID-19 pandemic in Texas Tasmiah Nuzhath, Kobi V. Ajayi, Qiping Fan, Peter Hotez, Brian Colwell, Timothy Callaghan, Annette K. Regan
68 [GO] 2021―Apr―27 The impact of disruptions caused by the COVID-19 pandemic on global polio eradication Dominika A. Kalkowska, Arie Voorman, Mark A. Pallansch, Steven G. F. Wassilak, Stephen L. Cochi, Kamran Badizadegan, Kimberly M. Thompson
69 [GO] 2021―Apr―24 Modelling of COVID-19 vaccination strategies and herd immunity, in scenarios of limited and full vaccine supply in NSW, Australia C Raina MacIntyre, Valentina Costantino, Mallory Trent
70 [GO] 2021―Apr―24 Factors Influencing Covid-19 Vaccine Acceptance across Subgroups in the United States: Evidence from a Conjoint Experiment S.E. Kreps, D.L. Kriner
71 [GO] 2021―Apr―15 Vaccination willingness, vaccine hesitancy, and estimated coverage at the first round of COVID-19 vaccination in China: a national cross-sectional study Chao Wang, Bingfeng Han, Tianshuo Zhao, Hanyu Liu, Bei Liu, Linyi Chen, et al. (+10)
72 [GO] 2021―Apr―09 The safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in Chinese adults aged 18-59 years: a phase I randomized, double-blinded, controlled trial Jing Pu, Qin Yu, Zhifang Yin, Ying Zhang, Xueqi Li, Qiongzhou Yin, et al. (+41)
73 [GO] 2021―Apr―08 Within-country age-based prioritisation, global allocation, and public health impact of a vaccine against SARS-CoV-2: a mathematical modelling analysis Alexandra B. Hogan, Peter Winskill, Oliver J. Watson, Patrick G.T. Walker, Charles Whittaker, Marc Baguelin, et al. (+14)
74 [GO] 2021―Apr―06 Impact of Reduced Human Papillomavirus Vaccination Coverage Rates Due to COVID-19 in the United States: A Model Based Analysis Vincent Daniels, Kunal Saxena, Craig Roberts, Smita Kothari, Shelby Corman, Linda Niccolai
75 [GO] 2021―Apr―06 When politics collides with public health: COVID-19 vaccine country of origin and vaccination acceptance in Brazil Wladimir G. Gramacho, Mathieu Turgeon
76 [GO] 2021―Apr―06 Anaphylactic reactions to mRNA COVID-19 vaccines: A call for further study Sophia Hatziantoniou, Helena C. Maltezou, Athanasios Tsakris, Gregory A. Poland, Cleo Anastassopoulou
77 [GO] 2021―Mar―26 strategy to identify priority groups for covid-19 vaccination: a population based cohort STUDY Antonio Giampiero Russo, Adriano Decarli, Maria Grazia Valsecchi
78 [GO] 2021―Mar―26 The Development of COVID-19 Vaccines in the United States: Why and How So Fast? Barbara J. Kuter, Paul Offit, Gregory A. Poland
79 [GO] 2021―Mar―24 COVID-19 vaccination attitudes, values and intentions among United States adults prior to emergency use authorization Daniel A. Salmon, Matthew Z. Dudley, Janesse Brewer, Lilly Kan, Jennifer E. Gerber, Haley Budigan, et al. (+4)
80 [GO] 2021―Mar―23 Are vaccines against COVID-19 tailored to the most vulnerable people? Raffaele Antonelli Incalzi, Caterina Trevisan, Susanna Del Signore, Stefano Volpato, Stefano Fumagalli, Fabio Monzani, et al. (+7)
81 [GO] 2021―Mar―23 COVID-19 Vaccine Safety Questions and Answers for Healthcare Providers (CONSIDER) Sonali Kochhar, Eve Dubé, Janice Graham, Youngmee Jee, Ziad A. Memish, Lisa Menning, et al. (+4)
82 [GO] 2021―Mar―23 Safeguarding evidence-based decision making in the FDA for COVID-19 vaccines Aris Angelis, Jonathan Darrow
83 [GO] 2021―Mar―23 The role of multiple SARS-CoV-2 viral antigens in a vaccine-induced integrated immune response Ying Zhang, Dandan Li, Heng Zhao, Lichun Wang, Yun Liao, Xueqi Li, et al. (+2)
84 [GO] 2021―Mar―23 Joining the Herd? U.S. Public Opinion and Vaccination Requirements Across Educational Settings During the COVID-19 Pandemic Simon F. Haeder
85 [GO] 2021―Mar―20 Projecting the impact of a two-dose COVID-19 vaccination campaign in Ontario, Canada Thomas N. Vilches, Kevin Zhang, Robert Van Exan, Joanne M. Langley, Seyed M. Moghadas
86 [GO] 2021―Mar―20 Safety monitoring of COVID-19 vaccines - Lessons learned from the 1976 national influenza immunization program about detecting rare vaccine-related severe adverse events in emergency mass-vaccination programs Alan Kendal
87 [GO] 2021―Mar―18 Media usage predicts intention to be vaccinated against SARS-CoV-2 in the US and the UK Daniel Allington, Siobhan McAndrew, Vivienne Louisa Moxham-Hall, Bobby Duffy
88 [GO] 2021―Mar―13 Developing standard safety outcomes for COVID-19 vaccines Jim P. Buttery
89 [GO] 2021―Mar―11 COVID-19 vaccination and critical care capacity: perilous months ahead Leslie A Reperant, Albert DME Osterhaus
90 [GO] 2021―Mar―11 COVID-19 vaccine intentions in the United States, a social-ecological framework Carl Latkin, Lauren Dayton, Grace Yi, Arianna Konstantopoulos, Ju Park, Catherine Maulsby, Xiangrong Kong
91 [GO] 2021―Mar―11 The social experience of participation in a COVID-19 vaccine trial: Subjects’ motivations, others’ concerns, and insights for vaccine promotion Emily Wentzell, Ana-Monica Racila
92 [GO] 2021―Mar―09 NIH funding for vaccine readiness before the COVID-19 pandemic Anthony E. Kiszewski, Ekaterina Galkina Cleary, Matthew J. Jackson, Fred D. Ledley
93 [GO] 2021―Mar―09 Importance of COVID-19 vaccine efficacy in older age groups Manish Sadarangani, Bahaa Abu Raya, Jessica M. Conway, Sarafa A. Iyaniwura, Rebeca Cardim Falcao, Caroline Colijn, et al. (+2)
94 [GO] 2021―Mar―09 U.S. Public Support for COVID-19 Vaccine Donation to Low- and Middle-Income Countries during the COVID-19 Pandemic Jeanine P.D. Guidry, Paul B. Perrin, Linnea I. Laestadius, Emily K. Vraga, Carrie A. Miller, Bernard F. Fuemmeler, et al. (+3)
95 [GO] 2021―Mar―07 The Critical Role Background Rates of Possible Adverse Events in the Assessment of COVID-19 Vaccine Safety Steven B Black, Barbara Law, Robert T. Chen, Cornelia L. Dekker, Miriam Sturkenboom, Wan-Ting Huang, et al. (+2)
96 [GO] 2021―Mar―07 Vaccine Hesitancy and Anti-Vaccination in the Time of COVID-19: a Google Trends Analysis Samuel Pullan, Mrinalini Dey
97 [GO] 2021―Mar―05 Influenza Vaccination in the Time of COVID-19: A National U.S. Survey of Adults Lynne Sturm, Monica L. Kasting, Katharine J. Head, Jane A. Hartsock, Gregory D. Zimet
98 [GO] 2021―Mar―05 Intranasal Administration of a Recombinant RBD Vaccine Induced Protective Immunity Against SARS-CoV-2 in Mouse Yingying Du, Yuhua Xu, Jin Feng, Longbo Hu, Yanan Zhang, Bo Zhang, et al. (+6)
99 [GO] 2021―Mar―05 Assessment of SARS-CoV-2 Specific CD4(+) and CD8 (+) T Cell Responses MHC Class I and II Tetramers Yuri Poluektov, Pirouz Daftarian, Marybeth George, Marc C. Delcommenne
100 [GO] 2021―Mar―02 Guidance for design and analysis of observational studies of fetal and newborn outcomes following COVID-19 vaccination during pregnancy Deshayne B. Fell, Michelle C. Dimitris, Jennifer A. Hutcheon, Justin R. Ortiz, Robert W. Platt, Annette K. Regan, David A. Savitz
101 [GO] 2021―Feb―27 Projected COVID-19 epidemic in the United States in the context of the effectiveness of a potential vaccine and implications for social distancing and face mask use Mingwang Shen, Jian Zu, Christopher K. Fairley, José A. Pagán, Li An, Zhanwei Du, et al. (+6)
102 [GO] 2021―Feb―27 Willingness to Pay and Financing Preferences for COVID-19 Vaccination in China Jiahao Wang, Yun Lyu, Haijun Zhang, Rize Jing, Xiaozhen Lai, Huangyufei Feng, et al. (+2)
103 [GO] 2021―Feb―24 Building the global vaccine manufacturing capacity needed to respond to pandemics Tara Kirk Sell, Daniel Gastfriend, Matthew Watson, Crystal Watson, Lauren Richardson, Anita Cicero, et al. (+2)
104 [GO] 2021―Feb―21 The potential effects of deploying SARS-Cov-2 vaccines on cold storage capacity and immunization workload in countries of the WHO African Region Justin R. Ortiz, Joanie Robertson, Jui-Shan Hsu, Stephen L. Yu, Amanda J. Driscoll, Sarah R. Williams, et al. (+5)
105 [GO] 2021―Feb―17 Perspectives on the Receipt of a COVID-19 Vaccine: A Survey of Employees in Two Large Hospitals in Philadelphia Barbara J. Kuter, Safa Browne, Florence M. Momplaisir, Kristen A. Feemster, Angela K. Shen, Judith Green-McKenzie, et al. (+2)
106 [GO] 2021―Feb―10 Improving COVID-19 Vaccine Acceptance: Including Insights from Human Decision-Making Under Conditions of Uncertainty and Human-Centered Design Caroline M. Poland, Allison Matthews, Gregory A. Poland
107 [GO] 2021―Feb―09 A preliminary report of a randomized controlled phase 2 trial of the safety and immunogenicity of mRNA-1273 SARS-CoV-2 vaccine Laurence Chu, Roderick McPhee, Wenmei Huang, Hamilton Bennett, Rolando Pajon, Biliana Nestorova, Brett Leav
108 [GO] 2021―Feb―07 International estimates of intended uptake and refusal of COVID-19 vaccines: A rapid systematic review and meta-analysis of large nationally representative samples Eric Robinson, Andrew Jones, India Lesser, Michael Daly
109 [GO] 2021―Feb―03 Ethical tradeoffs in SARS-CoV-2 vaccine development: Assuring fair availability for low-income countries David Gurwitz
110 [GO] 2021―Jan―31 Vaccines, masks, distancing and credibility: An urgent warning for pandemic management Paul H. Axelsen, Gregory A. Poland
111 [GO] 2021―Jan―29 General Determination of Causation Between Covid-19 Vaccines and Possible Adverse Events Lee M. Hampton, Rakesh Aggarwal, Stephen J.W. Evans, Barbara Law
112 [GO] 2021―Jan―22 The economics of global COVID vaccine administration during a pandemic - Why continue skin alcohol preparation as a costly but ineffective practice? Eric G. Poland, Darren K. McGuire, Tamar Ratishvili, Gregory A. Poland
113 [GO] 2021―Jan―22 Variable seasonal influenza vaccine effectiveness across geographical regions, age groups and levels of vaccine antigenic similarity with circulating virus strains: A systematic review and meta-analysis of the evidence from test-negative design studies after the 2009/10 influenza pandemic G.N. Okoli, F. Racovitan, T. Abdulwahid, C.H. Righolt, S.M. Mahmud
114 [GO] 2021―Jan―20 US FDA erratic approach to placebo-controlled trials after issuing an emergency use authorization for a COVID-19 vaccine Rafael Dal-Ré
115 [GO] 2021―Jan―20 Recombinant SARS-CoV-2 RBD with a built in T helper epitope induces strong neutralization antibody response Qiu-dong Su, Ye-ning Zou, Yao Yi, Li-ping Shen, Xiang-zhong Ye, Yang Zhang, et al. (+15)
116 [GO] 2021―Jan―19 Immunoinformatics prediction of overlapping CD8+ T-cell, IFN-γ and IL-4 inducer CD4+ T-cell and linear B-cell epitopes based vaccines against COVID-19 (SARS-CoV-2) Abiodun J. Fatoba, Leah Maharaj, Victoria T. Adeleke, Moses Okpeku, Adebayo A Adeniyi, Matthew A. Adeleke
117 [GO] 2021―Jan―13 The need for inclusion of pregnant women in COVID-19 vaccine trials Richard H. Beigi, Carleigh Krubiner, Denise J. Jamieson, Anne D. Lyerly, Brenna Hughes, Laura Riley, et al. (+2)
118 [GO] 2021―Jan―13 Black-white disparities in 2009 H1N1 vaccination among adults in the United States: A cautionary tale for the COVID-19 pandemic Andrew E. Burger, Eric N. Reither, Svenn-Erik Mamelund, Sojung Lim
119 [GO] 2021―Jan―11 Development of Vaccines for Influenza Disease: Opportunity Costs of the COVID-19 Pandemic Timothy L. Wiemken, Ana Santos Rutschman
120 [GO] 2021―Jan―11 Immuno-informatics approach for B-cell and T-cell Epitope based peptide vaccine design against novel COVID-19 virus Jitender Singh, Deepti Malik, Ashvinder Raina
121 [GO] 2021―Jan―11 Predictors of Intention to Vaccinate Against COVID-19: Results of a Nationwide Survey Jeanette B. Ruiz, Robert A. Bell
122 [GO] 2021―Jan―08 Short term impact of the COVID-19 pandemic on incidence of vaccine preventable diseases and participation in routine infant vaccinations in the Netherlands in the period March-September 2020 Marit Middeldorp, Alies van Lier, Nicoline van der Maas, Irene Veldhuijzen, Wieke Freudenburg, Nina M van Sorge, et al. (+3)
123 [GO] 2021―Jan―08 Acceptance of the COVID-19 vaccine based on the Health Belief Model: a population-based survey in Hong Kong Martin CS Wong, Eliza LY Wong, Junjie Huang, Annie WL Cheung, Kevin Law, Marc KC Chong, et al. (+6)
124 [GO] 2021―Jan―08 The potential public health and economic value of a hypothetical COVID-19 vaccine in the United States: use of cost-effectiveness modeling to inform vaccination prioritization Michele Kohli, Michael Maschio, Debbie Becker, Milton C. Weinstein
125 [GO] 2021―Jan―08 Anaphylactic reactions to novel mRNA SARS-CoV-2/COVID-19 vaccines John M Kelso
126 [GO] 2021―Jan―08 How should we conduct pandemic vaccination? Jane Williams, Chris Degeling, Jodie McVernon, Angus Dawson
127 [GO] 2021―Jan―03 Constructing an ethical framework for priority allocation of pandemic vaccines J Fielding, S.G. Sullivan, F. Beard, K. Macartney, J. Williams, A. Dawson, et al. (+6)
128 [GO] 2020―Dec―26 Childhood vaccinations: hidden impact of COVID-19 on children in Singapore Youjia Zhong, Hannah Eleanor Clapham, Ramkumar Aishworiya, Ying Xian Chua, Jancy Mathews, Mabel Ong, et al. (+5)
129 [GO] 2020―Dec―17 Timing of COVID-19 Vaccine Approval and Endorsement by Public Figures Scott E. Bokemper, Gregory A. Huber, Alan S. Gerber, Erin K. James, Saad B. Omer
130 [GO] 2020―Dec―17 Preferences for a COVID-19 vaccine in Australia Antonio Borriello, Daniel Master, Andrea Pellegrini, John M Rose
131 [GO] 2020―Dec―17 Global production capacity of seasonal and pandemic influenza vaccines in 2019 Erin Sparrow, James G Wood, Christopher Chadwick, Anthony T. Newall, Siranda Torvaldsen, Ann Moen, Guido Torelli
132 [GO] 2020―Dec―16 Broad cross-national public support for accelerated COVID-19 vaccine trial designs David Broockman, Joshua Kalla, Alexander Guerrero, Mark Budolfson, Nir Eyal, Nicholas P. Jewell, et al. (+2)
133 [GO] 2020―Dec―13 BCG vaccine: worrying proposal for COVID-19 Emanuel Sarinho, Ekaterini Goudouris, Dirceu Solé
134 [GO] 2020―Dec―13 Priority allocation of pandemic influenza vaccines in Australia - Recommendations of 3 community juries C. Degeling, J. Williams, S.M. Carter, R. Moss, P. Massey, G.L. Gilbert, et al. (+5)
135 [GO] 2020―Dec―11 Maintain and increase vaccination coverage in children, adolescents, adults and elderly people: Let's avoid adding epidemics to the pandemic P. Bonanni, I.F. Angelillo, A. Villani, P. Biasci, S. Scotti, R. Russo, et al. (+12)
136 [GO] 2020―Dec―10 An Inventory-Location Optimization Model for Equitable Influenza Vaccine Distribution in Developing Countries During the COVID-19 Pandemic Mehdi Rastegar, Madjid Tavana, Afshin Meraj, Hassan Mina
137 [GO] 2020―Dec―09 Potential impact of COVID-19 pandemic on vaccination coverage in children: A case study of measles-containing vaccine administration in the United States (US) Cristina Carias, Manjiri Pawaskar, Mawuli Nyaku, James H. Conway, Craig Roberts, Lyn Finelli, Ya-Ting Chen
138 [GO] 2020―Dec―09 Critical Aspects of Packaging, Storage, Preparation, and Administration of mRNA and Adenovirus-vectored COVID-19 Vaccines for Optimal Efficacy Michelle Holm, Gregory Poland
139 [GO] 2020―Dec―05 Epidemiology of COVID-19 infection in young children under five years: a systematic review and meta-analysis Mejbah Uddin Bhuiyan, Eunice Stiboy, Md. Zakiul Hassan, Mei Chan, Md. Saiful Islam, Najmul Haider, et al. (+2)
140 [GO] 2020―Dec―05 Individual Preferences for COVID-19 Vaccination in China Anli Leng, Elizabeth Maitland, Siyuan Wang, Stephen Nicholas, Rugang Liu, Jian Wang
141 [GO] 2020―Dec―05 PIPDeploy: Development and implementation of a gamified table top simulation exercise to strengthen national pandemic vaccine preparedness and readiness Ioana Ghiga, Sol Richardson, Alba Maria Ropero Álvarez, Masaya Kato, Dhamari Naidoo, Satoko Otsu, et al. (+3)
142 [GO] 2020―Dec―04 Pregnant people deserve the protection offered by SARS-CoV-2 vaccines Melanie M. Maykin, Cara Heuser, Helen Feltovich
143 [GO] 2020―Nov―24 A model for the incremental burden of invasive Haemophilus influenzae type b due to a decline of childhood vaccination during the COVID-19 outbreak: A dynamic transmission model in Japan Taito Kitano, Hirosato Aoki
144 [GO] 2020―Nov―24 How to ensure we can track and trace the global use of COVID-19 vaccines? Robert H Vander Stichele, Christian Hay, Malin Fladvad, Miriam CJM Sturkenboom, Robert T Chen
145 [GO] 2020―Nov―24 New vaccine production platforms used in developing SARS-CoV-2 vaccine candidates Takehiro Ura, Akio Yamashita, Nobuhisa Mizuki, Kenji Okuda, Masaru Shimada
146 [GO] 2020―Nov―08 Pandemic perspectives - The invisible hurricane Carly Muller
147 [GO] 2020―Nov―07 The demand for a COVID-19 vaccine in Ecuador Oscar Sarasty, Carlos E. Carpio, Darren Hudson, Patricia A. Guerrero-Ochoa, Ivan Borja
148 [GO] 2020―Nov―05 Influenza vaccination among infection control teams: A EUCIC survey prior to COVID-19 pandemic Şiran Keske, Nico T. Mutters, Constantinos Tsioutis, Önder Ergönül
149 [GO] 2020―Nov―05 COVID-19: The Worst Date to the Senior Dance Luke Bothun
150 [GO] 2020―Oct―30 The public’s role in COVID-19 vaccination: human-centered recommendations to enhance pandemic vaccine awareness, access, and acceptance in the United States Monica Schoch-Spana, Emily K. Brunson, Rex Long, Alexandra Ruth, Sanjana J. Ravi, Marc Trotochaud, et al. (+17)
151 [GO] 2020―Oct―28 Key criteria for the ethical acceptability of COVID-19 human challenge studies: Report of a WHO Working Group Euzebiusz Jamrozik, Katherine Littler, Susan Bull, Claudia Emerson, Gagandeep Kang, Melissa Kapulu, et al. (+7)
152 [GO] 2020―Oct―26 “Cultivating” acceptance of a COVID-19 vaccination program: Lessons from Italy Guendalina Graffigna, Lorenzo Palamenghi, Serena Barello, Boccia Stefania
153 [GO] 2020―Oct―26 Acceptance of a COVID-19 vaccine: A multifactorial consideration Leidy Y. García, Arcadio A. Cerda
154 [GO] 2020―Oct―23 NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challenge Mimi Guebre-Xabier, Nita Patel, Jing-Hui Tian, Bin Zhou, Sonia Maciejewski, Kristal Lam, et al. (+7)
155 [GO] 2020―Oct―21 “Expanding Global and National Influenza Vaccine Systems to match the COVID-19 Pandemic Response” Bruce A. Ruscio, Peter Hotez
156 [GO] 2020―Oct―20 India’s cost-effective COVID-19 vaccine development initiatives Chiranjib Chakraborty, Govindasamy Agoramoorthy
157 [GO] 2020―Oct―19 Parents’ and guardians’ views on the acceptability of a future COVID-19 vaccine: a multi-methods study in England Sadie Bell, Richard Clarke, Sandra Mounier-Jack, Jemma L Walker, Pauline Paterson
158 [GO] 2020―Oct―19 Identification of a dominant CD8+ CTL epitope in the SARS-associated coronavirus 2 spike protein Daisuke Muraoka, Deng Situo, Sawada Shin-ichi, Akiyoshi Kazunari, Naozumi Harada, Hiroaki Ikeda
159 [GO] 2020―Oct―13 Exploring uncertainty and risk in the accelerated response to a COVID-19 vaccine: Perspective from the pharmaceutical industry L. Coudeville, G.B. Gomez, O. Jollivet, R.C. Harris, E. Thommes, S. Druelles, et al. (+3)
160 [GO] 2020―Oct―10 Caregiver willingness to vaccinate their children against COVID-19: cross sectional survey Ran D. Goldman, Tyler D. Yan, Michelle Seiler, Cristina Parra Cotanda, Julie C. Brown, Eileen J. Klein, et al. (+17)
161 [GO] 2020―Oct―09 COVID-19 in Africa and collateral effects on health systems and their immunization programs Azucena Bardají, Quique Bassat, Graça Matsinhe, Teresa Aguado
162 [GO] 2020―Oct―09 COVID-19 vaccine and boosted immunity: nothing ad interim to do? Luca Roncati, Maria Vadalà, Veronica Corazzari, Beniamino Palmieri
163 [GO] 2020―Oct―09 COVID-19 vaccine trials: duty of care and standard of prevention considerations Jerome Amir Singh
164 [GO] 2020―Oct―09 Exploring the out of sight antigens of SARS-CoV-2 to design a candidate multi-epitope vaccine by utilizing immunoinformatics approaches Ashkan Safavi, Amirhosein Kefayat, Elham Mahdevar, Ardavan Abiri, Fatemeh Ghahremani
165 [GO] 2020―Sep―22 Yeast-Expressed SARS-CoV Recombinant Receptor-Binding Domain (RBD219-N1) Formulated with Aluminum Hydroxide Induces Protective Immunity and Reduces Immune Enhancement Wen-Hsiang Chen, Xinrong Tao, Anurodh Agrawal, Abdullah Algaissi, Bi-Hung Peng, Jeroen Pollet, et al. (+7)
166 [GO] 2020―Sep―22 Enhanced Elicitation of Potent Neutralizing Antibodies by the SARS-CoV-2 Spike Receptor Binding Domain Fc Fusion Protein in Mice Xianglei Liu, Aleksandra Drelich, Wei Li, Chuan Chen, Zehua Sun, Megan Shi, et al. (+4)
167 [GO] 2020―Sep―17 Intention to participate in a COVID-19 vaccine clinical trial and to get vaccinated against COVID-19 in France during the pandemic Maëlle Detoc, Sébastien Bruel, Paul Frappe, Bernard Tardy, Elisabeth Botelho-Nevers, Amandine Gagneux-Brunon
168 [GO] 2020―Sep―15 Ensemble forecast modeling for the design of COVID-19 vaccine efficacy trials Natalie E. Dean, Ana Pastore y Piontti, Zachary J. Madewell, Derek A.T Cummings, Matthew D.T. Hitchings, Keya Joshi, et al. (+4)
169 [GO] 2020―Sep―10 Intention of nurses to accept coronavirus disease 2019 vaccination and change of intention to accept seasonal influenza vaccination during the coronavirus disease 2019 pandemic: a cross-sectional survey Kailu WANG, Eliza Lai Yi WONG, Kin Fai HO, Annie Wai Ling CHEUNG, Emily Ying-yang CHAN, Eng Kiong YEOH, Samuel Yeung-shan WONG
170 [GO] 2020―Aug―20 Acceptability of a COVID-19 Vaccine among Adults in the United States: How Many People Would Get Vaccinated? Paul L. Reiter, Michael L. Pennell, Mira L. Katz
171 [GO] 2020―Aug―20 BCG vaccine may generate cross-reactive T cells against SARS-CoV-2: in silico analyses and a hypothesis Yusuke Tomita, Ryo Sato, Tokunori Ikeda, Takuro Sakagami
172 [GO] 2020―Aug―19 The impact of influenza vaccination on the COVID-19 pandemic? Evidence and lessons for public health policies John Paget, Saverio Caini, Ben Cowling, Susanna Esposito, Ann R. Falsey, Angela Gentile, et al. (+4)
173 [GO] 2020―Aug―19 Amplifying immunogenicity of prospective Covid-19 vaccines by glycoengineering the coronavirus glycan-shield to present α-gal epitopes Uri Galili
174 [GO] 2020―Aug―15 Impact of COVID-19 pandemic response on uptake of routine immunizations in Sindh, Pakistan: an analysis of provincial electronic immunization registry Subhash Chandir, Danya Arif Siddiqi, Mariam Mehmood, Hamidreza Setayesh, Muhammad Siddique, Amna Mirza, et al. (+7)
175 [GO] 2020―Aug―10 The effect of Bacillus Calmette-Guérin (BCG) vaccination in preventing sever infectious respiratory diseases other than TB: Implications for the COVID-19 pandemic Kiddus Yitbarek, Gelila Abraham, Tsinuel Girma, Tizta Tilahun, Mirkuzie Woldie
176 [GO] 2020―Jul―31 Ensuring access and affordability through COVID-19 vaccine research and development investments: a proposal for the Options Market for Vaccines Rebecca Forman, Michael Anderson, Mark Jit, Elias Mossialos
177 [GO] 2020―Jul―29 Influenza immunization and COVID-19 Helena C. Maltezou, Kalliopi Theodoridou, Gregory Poland
178 [GO] 2020―Jul―12 Vaccines based on Virus-Like nano-Particles for use against Middle East Respiratory Syndrome (MERS) coronavirus Alireza Hashemzadeh, Amir Avan, Gordon A Ferns, Majid Khazaei
179 [GO] 2020―Jul―10 Planning for COVID-19 Vaccines Safety surveillance Sonali Kochhar, Daniel A. Salmon
180 [GO] 2020―Jul―03 A global agenda for older adult immunization in the COVID-19 era: A roadmap for action Lois A. Privor-Dumm, Gregory A. Poland, Jane Barratt, David N. Durrheim, Maria Deloria Knoll, Prarthana Vasudevan, et al. (+3)
181 [GO] 2020―Jul―03 Bacillus Calmette-Guérin vaccine, antimalarial, age and gender relation to COVID-19 spread and mortality Ahmed Osama El-Gendy, Haitham Saeed, Ahmed M.A. Ali, Hossam M. Zawbaa, Dina Gomaa, Hadeer S. Harb, et al. (+4)
182 [GO] 2020―Jun―25 Contingent assessment of the COVID-19 vaccine Leidy Y. García, Arcadio A. Cerda
183 [GO] 2020―Jun―25 Silver Lining of COVID-19: heightened global interest in pneumococcal and influenza vaccines, an infodemiology study Joseph Alexander Paguio, Jasper Seth Yao, Edward Christopher Dee
184 [GO] 2020―Jun―24 Recombinant SARS-CoV-2 spike S1-Fc fusion protein induced high levels of neutralizing responses in nonhuman primates Wenlin Ren, Hunter Sun, George F. Gao, Jianxin Chen, Sean Sun, Rongqing Zhao, et al. (+18)
185 [GO] 2020―Jun―23 Logistical challenges for potential SARS-CoV-2 vaccine and a call to research institutions, developers and manufacturers Umit H. Kartoglu, Kelly L. Moore, John S. Lloyd
186 [GO] 2020―Jun―23 Allocation criteria for an initial shortage of a future SARS-CoV-2 vaccine and necessary measures for global immunity Wolfram Henn
187 [GO] 2020―Jun―20 Exploring the role of mass immunisation in influenza pandemic preparedness: A modelling study for the UK context Luca Grieco, Jasmina Panovska-Griffiths, Edwin van Leeuwen, Peter Grove, Martin Utley
188 [GO] 2020―Jun―19 Use of seasonal influenza and pneumococcal polysaccharide vaccines in older adults to reduce COVID-19 mortality Deus Thindwa, Maria Garcia Quesada, Yang Liu, Julia Bennett, Cheryl Cohen, Maria Deloria Knoll, et al. (+3)
189 [GO] 2020―Jun―10 Vaccination Against Coronaviruses In Domestic Animals Ian R Tizard
190 [GO] 2020―Jun―04 COVID-19 vaccine development: Time to consider SARS-CoV-2 challenge studies? G. Owen Schaefer, Clarence C. Tam, Julian Savulescu, Teck Chuan Voo
191 [GO] 2020―May―25 Consensus Summary Report for CEPI/BC March 12-13, 2020 Meeting: Assessment of Risk of Disease Enhancement with COVID-19 Vaccines Paul-Henri Lambert, Donna M. Ambrosino, Svein R. Andersen, Ralph S. Baric, Steven B. Black, Robert T. Chen, et al. (+11)
192 [GO] 2020―May―01 Tortoises, Hares, and Vaccines: A Cautionary Note for SARS-CoV-2 Vaccine Development Gregory A. Poland
193 [GO] 2020―Apr―30 The biological characteristics of SARS-CoV-2 Spike protein Pro330-Leu650 Qiu-dong Su, Yao Yi, Ye-ning Zou, Zhi-yuan Jia, Feng Qiu, Feng Wang, et al. (+7)
194 [GO] 2020―Apr―28 An Effective CTL Peptide Vaccine for Ebola Zaire Based on Survivors’ CD8+ Targeting of a Particular Nucleocapsid Protein Epitope with Potential Implications for COVID-19 Vaccine Design C.V. Herst, S. Burkholz, J. Sidney, A. Sette, P.E. Harris, S. Massey, et al. (+10)
195 [GO] 2020―Apr―20 Enabling Emergency Mass Vaccination: Innovations in Manufacturing and Administration During a Pandemic Divya Hosangadi, Kelsey Lane Warmbrod, Elena K Martin, Amesh Adalja, Anita Cicero, Thomas Inglesby, et al. (+3)
196 [GO] 2020―Mar―12 Shaping meeting to explore the value of a coordinated work plan for epidemic and pandemic influenza vaccine preparedness Bruce Ruscio, Amanda Bolster, Joseph Bresee, Atika Abelin, Philippe Boutet, Hans Christiansen, et al. (+23)
197 [GO] 2020―Feb―21 Another coronavirus, another epidemic, another warning Gregory A. Poland
198 [GO] 2020―Feb―11 Recombinant infectious bronchitis coronavirus H120 with the spike protein S1 gene of the nephropathogenic IBYZ strain remains attenuated but induces protective immunity Yi Jiang, Xu Cheng, Xiumei Zhao, Yan Yu, Mingyan Gao, Sheng Zhou
199 [GO] 2020―Jan―24 Pandemic influenza A(H1N1pdm09) vaccine induced high levels of influenza-specific IgG and IgM antibodies as analyzed by enzyme immunoassay and dual-mode multiplex microarray immunoassay methods Anna Kazakova, Laura Kakkola, Thedi Ziegler, Ritva Syrjänen, Henna Päkkilä, Matti Waris, et al. (+2)
200 [GO] 2019―Dec―12 Does having a seasonal influenza program facilitate pandemic preparedness? An analysis of vaccine deployment during the 2009 pandemic Rachael M. Porter, Shoshanna Goldin, Kathryn E. Lafond, Lisa Hedman, Mellissa Ungkuldee, Jordan Kurzum, et al. (+4)


Last change 2021―Jun―30 20:09:44 UTC

© Daten-Quadrat 2021       Done in 0.006 sec